PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31167986-3	2019	TC-G 1008 also suppressed serum interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha significantly at 6 h after the elicitation, suggesting that the cells producing IL-6 and/or TNF-alpha are the targets of TC-G 1008.	GPR39-C3	0-9	interleukin 6	Mus musculus	32-50	
31167986-3	2019	TC-G 1008 also suppressed serum interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha significantly at 6 h after the elicitation, suggesting that the cells producing IL-6 and/or TNF-alpha are the targets of TC-G 1008.	GPR39-C3	0-9	interleukin 6	Mus musculus	169-173	
31167986-3	2019	TC-G 1008 also suppressed serum interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha significantly at 6 h after the elicitation, suggesting that the cells producing IL-6 and/or TNF-alpha are the targets of TC-G 1008.	GPR39-C3	210-219	interleukin 6	Mus musculus	169-173	
31167986-4	2019	One potential target cell appears to be a monocyte-derived macrophages because TC-G 1008 treatment suppressed lipopolysaccharide-induced IL-6 production from U937 macrophages in vitro.	GPR39-C3	79-88	interleukin 6	Mus musculus	137-141